- NSE
- CONCORDBIO
- BSE
- 543960
- ISIN
- INE338H01029
CONCORD BIOTECH
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹596.80
−₹35.80 (−5.66%)
NSE close ·
CONCORD BIOTECH closed at ₹596.80 on 9 Nov 2026, down 5.66% on the day, and is down 14.43% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹596.80 to ₹1,587.50.
Price returns, excl. dividends. 3Y and Max are annualised. 5Y appears once the stock has that much history.
Fundamentals
- Market cap
- ₹12,487 Cr
- Industry P/E
- 35.5
- Dividend yield
- 0.63%
Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹270 Cr | ₹57.70 Cr | — | ₹2.76 |
Armor risk check
CONCORD BIOTECH moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is CONCORD BIOTECH's share price today?
CONCORD BIOTECH (NSE: CONCORDBIO) closed at ₹596.80 on 9 Nov 2026, down 5.66% from the previous close of ₹632.60. It traded between ₹592.50 and ₹625.20 that day.
What are CONCORD BIOTECH's 52-week high and low?
Over the last 52 weeks CONCORD BIOTECH traded between ₹493.50 and ₹807.50, adjusted for splits and bonuses.
What are CONCORD BIOTECH's NSE symbol, BSE code and ISIN?
CONCORD BIOTECH has NSE symbol CONCORDBIO, BSE code 543960, ISIN INE338H01029.
How has CONCORD BIOTECH performed over 1, 3 and 5 years?
CONCORD BIOTECH's share price return: 1Y −14.43%, 3Y −4.67% a year. Dividends are not included.
Does CONCORD BIOTECH pay a dividend?
Yes. CONCORD BIOTECH's latest dividend went ex on 24 Jul 2026: Final · ₹7.55 per share. Dividends over the past year come to a yield of 0.63% at the latest close.
What is CONCORD BIOTECH's market cap?
CONCORD BIOTECH's market cap is ₹12,487 Cr at the close on 9 Nov 2026.
Which sector is CONCORD BIOTECH in?
CONCORD BIOTECH is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how CONCORD BIOTECH fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app